Urotensin I (TFA)

Urotensin I (Catostomus urotensin I) TFA, a CRF-like neuropeptide, acts as an agonist of CRF receptor with pEC50s of 11.46, 9.36 and 9.85 for human CRF1, human CRF2 and rat CRF2α receptors in CHO cells, and Kis of 0.4, 1.8, and 5.7 nM for hCRF1, rCRF2α and mCRF2β receptors, respectively[1][2].

Product Specifications

Product Name Alternative

Catostomus urotensin I (TFA)

UNSPSC

12352209

Target

CRFR

Type

Peptides

Related Pathways

GPCR/G Protein

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Endocrinology; Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/urotensin-i-tfa.html

Purity

95.77

Solubility

10 mM in DMSO

Smiles

[NDDPPISIDLTFHLLRNMIEMARIENEREQAGLNRKYLDEV-NH2(TFAsalt)]

Molecular Formula

C210H340N62O67S2.xC2HF3O2

Molecular Weight

4869.46 (free base)

References & Citations

[1]Smart D, et al. Characterisation using microphysiometry of CRF receptor pharmacology. Eur J Pharmacol. 1999 Aug 27;379 (2-3) :229-35.|[2]Reul JM, et al. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr Opin Pharmacol. 2002 Feb;2 (1) :23-33.|[3]Fryer J, et al. Urotensin I, a CRF-like neuropeptide, stimulates acth release from the teleost pituitary. Endocrinology. 1983;113 (6) :2308-2310.|[4]Gerritsen ME, et al. Urotensin I effects on intracellular content of cyclic AMP in the rat tail artery. Eur J Pharmacol. 1979;60 (2-3) :211-220.